Blueprint: Inside KKR’s latest fund, AXA’s long view on life science, the lowdown on special servicers

How special servicers have worked to avoid a repeat of 2008; KKR's high hopes for its latest opportunistic fund; AXA's long-hold strategy for life science; and more in today's briefing, exclusively for our valued subscribers.